Company intelligence / Profile preview
PolyActiva
Melbourne, Victoria, Australiapolyactiva.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
PolyActiva has demonstrated promising interim Phase 2a results with its lead PA5108 Ocular Implant in patients with mild to moderate glaucoma. The implant delivers latanoprost over six months, achieving >20% intraocular pressure reduction at both three and six months. Repeat dosing was shown to be feasible, with no product-related adverse effects reported. In a separate cohort, clinically meaningful IOP reductions of up to ~35% were observed over a total of nearly one year when two implants were administered sequentially. Most patients did not require additional drop therapy during this period.
- Therapeutic areas
- OphthalmologyInfectious Diseases
- Modalities
- Small molecules (delivered via polymeric prodrug ocular implants)Biodegradable drug delivery devices/implants
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Venture capital partnerships include Brandon Capital’s Medical Research Commercialisation Fund (MRCF)Yuuwa CapitalBiomedical Translation Fund support from Australian government initiatives.
Beyond the preview
Go deeper on PolyActiva.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PolyActiva.